| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,540 | 5,829 | 5,774 | 27,807 | | Cost of Revenue | 2,899 | 2,830 | 4,584 | 13,351 | | | Gross Profit | 1,641 | 2,999 | 1,190 | 14,456 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,725 | 3,832 | 7,449 | 14,510 | | Non Recurring |
-
| 308 | 1,229 | 41,108 | | Others | 492 | 479 | 553 | 5,597 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,576) | (1,620) | (8,041) | (46,759) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 51 | 662 | (9,224) | 889 | | Earnings Before Interest And Taxes | (406) | (958) | (17,265) | (45,870) | | Interest Expense | 182 | 185 | 1,307 | 1,954 | | Income Before Tax | (588) | (1,143) | (18,572) | (47,824) | | Income Tax Expense | 975 | 66 | (2,646) | 1,903 | | Minority Interest |
-
|
-
| 11 | 64 | | | | Net Income From Continuing Ops | (3,682) | (1,209) | (15,915) | (49,663) | | | Non-recurring Events | | Discontinued Operations | (963) | (4) | 7,246 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,645) | (1,213) | (8,669) | (49,663) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,645) | ($1,213) | ($8,669) | ($49,663) |
|
0.26% Nasdaq 
0.03 (2.97%) 
Income Statement
